ENDEAVOUR-Breast Open for Application NOW

Munich – (23 May, 2022) – Daiichi Sankyo Europe is starting the second edition of its ENDEAVOUR-Breast programme. Application is now open for researchers who are employed at university hospitals or other academic institutions, active in breast cancer research and who already have pertinent publications as first or last authors in peer-reviewed journals. Applications should be submitted before 31st of July 2022 via the application form on the website www.endeavourbreastprogramme.com. A Steering Committee will then select candidates from each country for the final selection for which applicants will be required to prepare a short proposal for a scientific project.
 

3-year programme aims to address need for continued progress in breast cancer therapy and research

Breast cancer is one of the world’s most prevalent forms of cancer, and in spite of recent advances in treatment, many challenges remain. There is a need for continued progress in therapy and research through international collaboration and education. This is the goal of the Endeavour-Breast programme.

Like the successful previous edition, the second ENDEAVOUR-Breast programme will run over three years and involve

  • Current oncologic research including recent clinical trial updates as well as participants’ own research
  • Methodological topics, such as writing competitive research grants and conducting clinical trials
  • Personal mentoring by the Steering Committee

Past participants highly recommend the programme

Feedback from the 1st edition was overwhelmingly positive, with 81.8% of attendees and faculty members rating the program as ‘excellent’. “The ENDEAVOUR does not end after the three years. Actually, I am still in touch with some people I met, not only discussing clinical questions and clinical trials, but also in the development of new projects, – hoping to create more knowledge that would translate into better care of the patients in the future,” says Marta Vaz Batista, Medical Oncologist at Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal). “ENDEAVOUR is definitely an opportunity not to be missed, if you are lucky to be selected,“ agrees Matteo Lambertini, Associate Professor in medical oncology at the IRCCS Ospedale Policlinico San Martino, University of Genova in Genova (Italy).

back to top

User login

Enter your username and password here in order to log in on the website